Inogen, Inc. (INGN)
5.825
+0.14
(+2.37%)
USD |
NASDAQ |
Feb 18, 16:00
5.825
0.00 (0.00%)
After-Hours: 17:47
Inogen EPS Diluted (Quarterly) : -0.1955 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Intuitive Surgical, Inc. | 2.205 |
| IDEXX Laboratories, Inc. | 3.08 |
| Glaukos Corp. | -0.2828 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.294M |
| Revenue (Quarterly) | 92.39M |
| Total Expenses (Quarterly) | 97.68M |
| Enterprise Value | 48.19M |
| Gross Profit Margin (Quarterly) | 54.36% |
| Profit Margin (Quarterly) | -5.73% |
| Earnings Yield | -17.24% |
| Normalized Earnings Yield | -16.65 |